• News Archive
  • Simaster
  • Webmail
  • Directory
  • Crisis Center
  •  English
    • Indonesia
Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada
  • Education
    • Doctoral dissertation
    • Inauguration of Professor
    • Graduation
  • Achievement
  • Research and Innovation
    • Research
    • Innovation
  • Campus Info
    • Cooperation
    • Seminar and Workshop
    • Student Community Service Program
    • Other
  • News Report
  • Home
  • News Report
  • Ivermectin for COVID-19 Treatment: Expert Says Further Studies Needed

Ivermectin for COVID-19 Treatment: Expert Says Further Studies Needed

  • 25 June 2021, 12:27 WIB
  • By: Salma
  • 3474
Pakar UGM Ingatkan Masyarakat Jangan Asal Konsumsi Obat untuk Covid-19

In response to the debate over COVID-19 potential drug ivermectin, Professor at the UGM Faculty of Pharmacy Zullies Ikawati warned the public against its use without a prescription. According to her, ivermectin has not received approval for use to cure or prevent COVID-19, and its dosage guidelines and consumption rules remain unknown.  

Ivermectin is an anti-parasitic drug to treat people with specific parasitic infestations and animals with heartworm disease and certain parasites. She explained that the drug was not common in Indonesia because the particular worms or parasites it cured were rare. Current circulation was intended mostly for animals.

“There is much-unverified information circulating on Whatsapp. We don’t know whether it is safe or those claiming the drug to be proven are true. Non-prescribed use of the drug may cause harm,” she said.

Professor Zullies added that several countries had conducted initial studies and clinical trials to prove its efficacy for COVID-19 therapies. Dosage and duration of use varied per country. In Australia, some researchers published their in vitro findings regarding the potential of ivermectin to have an antiviral effect on SARS-CoV-2. However, she examined that a mere in vitro study was insufficient to ensure its effectiveness and safety for humans.

“Our Drug and Food Control Agency can use clinical trials data from those countries as long as the number of subjects is adequate and methodology, dosage, and outcome parameters are appropriate,” she said.

She advised the public to cross-examine those COVID-19 survivors who claimed to have recovered from taking this drug. It needed further studies and comparative data to be labeled proven. Moreover, current treatment guidelines have already included many other proven drugs for COVID-19 therapies. For safety, kindly only consume those prescribed by doctors.

“There must be further research to determine whether ivermectin is effective and takes part in the cause of those survivors’ recovery. Don’t ever use it without a prescription,” said Zullies.

Author: Gloria

Related News

  • Discovering Convalescent Therapy as an Alternative to Covid-19 Treatment

    Wednesday,01 July 2020 - 17:09
  • The Aging Population Has Not Fully Earned Social Care Insurance from the Government

    Monday,08 June 2020 - 13:38
  • UGM Academic Hospital's Doctor Reveals A New Symptom of Covid Tongue

    Monday,01 February 2021 - 11:44
  • UGM Expert: Preparation Tips before Getting Covid-19 Vaccine

    Friday,12 March 2021 - 20:41
  • Corn Silks to Overcome Osteoporosis

    Monday,18 January 2016 - 11:00

News Releases

  • Geography Alumna’s Aromatic Telon Oil Habbie Named 2023 Indonesia Brand Champion 03 February 2023
    Novita Anggraeni, an alumna of the UGM Faculty of Ge
    Salma
  • Bimasakti UGM Kicks Off Hybrid Technology Research 03 February 2023
    Bimasakti UGM has started researching hybrid technol
    Salma
  • 18,964 UGM Students Receive Scholarships, Director of Student Affairs Says 20 January 2023
    Universitas Gadjah Mada (UGM) annually allocates hundreds
    Salma
  • Prof. Budi Setiadi Daryono Recounts Origin of His Apple Melon Cultivar 'Hikapel' 16 January 2023
    In 2012, a team of researchers from the UGM Facult
    Salma
  • UGM Graduate Fajar Kelana Named Top 20 International James Dyson Award Winner 13 January 2023
    Fajar Sidik Abdullah Kelana, an alumnus of UGM and
    Salma

Event

No latest event at this time

Universitas Gadjah Mada
UNIVERSITAS GADJAH MADA
Bulaksumur Yogyakarta 55281
   info@ugm.ac.id
   +62 (274) 588688
   +62 (274) 565223
   +62 811 2869 988

PARTNERSHIP

  • Alumni
  • International Affairs

ABOUT UGM

  • Rector's Welcome
  • History
  • Vission and Mission
  • The Board of Executive
  • Management

VISIT UGM

  • Campus Map
  • Event

REGISTRATION

  • Undergraduate
  • Graduate
  • Vocational School
  • Professional Program
  • International Program

© 2023 Universitas Gadjah Mada

PRIVACY POLICYCONTACT